Medtronic in Charts: Cardiovascular and Diabetes post mid-teens growth in FQ3
Source: SeekingAlpha
2026-02-17 07:15:34 ET
More on Medtronic plc
- Medtronic: Navigating Tariffs And Chinese VBP Challenges
- Medtronic: A Healthier Diagnosis
- Medtronic: Don't Miss Out On This Dividend Aristocrat Now
- Medtronic plc Non-GAAP EPS of $1.36 beats by $0.02, revenue of $9B beats by $110M
- Earnings Scorecard: Healthcare sector shows strong top-line pulse
Read the full article on Seeking Alpha
For further details see:
Medtronic in Charts: Cardiovascular and Diabetes post mid-teens growth in FQ3
Medtronic plc.
NASDAQ: MDT
MDT Trading
-0.44% G/L:
$90.34 Last:
3,689,665 Volume:
$91.21 Open:
MDT Latest News
March 10, 2026 06:45:00 am
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
MDT Stock Data
$130,938,521,134
1,269,194,066
0.03%
8
N/A
Medical Equipment & Supplies
Healthcare
IE
Galway
